U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07395635) titled 'Phase II Trial of Immunonutrition in Hepatectomy' on Jan. 29.
Brief Summary: A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
Study Start Date: Oct. 03, 2025
Study Type: INTERVENTIONAL
Condition:
Hepatocellular Carcinoma
ASA I-III Patients
Intervention:
DIETARY_SUPPLEMENT: Immunonutrition
In addition to their usual intake, patients in the intervention arm will be prescribed for each of the 7 consecutive days preceding surgery 6-9 scoops PENTASURE Immunomax(R) powder (120-180g per day)
Recruitment Status: RECRUITING
Sponsor: Tata Memorial Centre...